Cold Exposure Therapy for Alzheimer's Disease
Also known as: Cold water immersion, Cryotherapy, Cold plunge, Wim Hof method
Cold exposure induces RBM3 — a cold shock protein that prevents synaptic loss and promotes synapse regeneration in neurodegeneration.
Mechanism of Action
Cold exposure activates RBM3 (RNA-binding motif protein 3), which prevents synapse loss and promotes synapse regeneration. It also activates brown adipose tissue (BAT), improving metabolic health and insulin sensitivity. Cold-induced norepinephrine release enhances attention and reduces neuroinflammation.
General mechanism: Hormetic cold stress. RBM3/CIRP cold shock proteins, norepinephrine release, NK cell activation, BAT activation, anti-inflammatory.
Current Evidence
RBM3 discovery (Bhatt et al., Nature 2014) showed cold-induced synapse protection in prion and AD models. Epidemiological data on winter swimming and cognitive resilience. Clinical translation in early stages.
Clinical Status: Preclinical (RBM3 mechanism). Epidemiological support. Clinical translation early.
Safety Profile
Generally safe with gradual adaptation. Cardiac arrhythmia risk in cold water. Contraindicated in Raynaud's, unstable cardiac disease. Supervision recommended for neurological patients.
Key Research Questions
- Can cold exposure induce sufficient RBM3 for synaptic protection in humans?
- Does regular cold exposure reduce AD biomarkers?